Document is current
Any future updates will be listed below
-
Authors
Ingrasci, Giuseppe
El-Kashlan, Nour
Alexis, Andrew
Yosipovitch, Gil
- License Information
-
More Information
Article History
Received: 10 March 2021
Accepted: 5 June 2021
First Online: 15 June 2021
Declarations
:
: Giuseppe Ingrasci: None. Nour El-Kashlan: None. Andrew Alexis: serves as a principal investigator for clinical trials and received research grants from Menlo, Galderma, LEO, Novartis, Sanofi-Regeneron, Amgen. Has received honoraria for serving as a consultant/on the advisory board for Menlo, Galderma, LEO, Novartis, Sanofi-Regeneron, Dermavant. Gil Yosipovitch: is a consultant for: Pfizer, Galderma, Sanofi Regeneron, Kiniksa, Trevi, Eli Lilly, Novartis, GSK, Leo and Bellus, has received grant/research support from Leo Pharma, Pfizer, Novartis and Kiniksa, Sanofi, Regeneron.
